The purposes of this study are:~to investigate the characteristics of treatment responders to galantamine by examining the clinical response of galantamine in patients with mild to moderate AD for 52 weeks.~to examine the specific cognitive sub-domains that are more sensitive to galantamine administration.
To investigate the characteristics of treatment responders to galantamine.